Federal Circuit Review | August 2024
August 2024 Federal Circuit Newsletter(Japanese) August 2024 Federal Circuit Newsletter (Chinese) Specify the Steps of Information Manipulation or Lose under § 101 In Mobile Acuity Ltd. v. Blippar Ltd., Appeal...
FDA Approves First mRNA-Based Flu Vaccine, Highlighting Growing Patent Value in mRNA Platforms
Key Takeaway: The FDA’s approval of mFLUSIVA may indicate increased commercial and strategic value of mRNA vaccine patents. On August 5, 2026, Moderna announced that the U.S. Food and Drug...
Federal Circuit Review | July 2026
PTAB May Revisit Issues Left Unresolved by Prior Appeal In Intellectual Pixels Limited v. Sony Interactive Entertainment LLC, Appeal No. 24-2174, The Board did not exceed the Federal Circuit’s mandate...